Literature DB >> 20156369

Acquired cholesteatoma pathogenesis: stepwise explanations.

Louise Louw1.   

Abstract

BACKGROUND: Since Virchow's first, 1855 publication on cholesteatoma, this disease has been the subject of extensive debate. The pathogenesis of acquired cholesteatoma is repeatedly explained on the premises of the migration, hyperplasia and metaplasia theories, but proof for the latter theory remains limited. In retrospect, there is progress toward better understanding of all the pathological mechanisms involved, as expounded in this review. DISCUSSION: The triggers for cholesteatoma onset are diverse, and may involve tympanic membrane trauma (i.e. perforation, displacement, retraction or invagination), tympanic membrane disease, and/or tympanic cavity mucosa disease. Research has revealed that cell migration is replaced under inflammatory conditions by hyperplasia, which triggers the onset of cholesteatoma. Lately, the hyperplasia theory gained prominence and circumscription of the papillary cone formation concept provided insight into cholesteatoma progression (growth and expansion). Diseased mucosa can contribute to the development of retraction pockets and cholesteatoma. The type of cholesteatoma trigger and the role of chronic inflammation during disease progression and recurrence are important in guiding clinical intervention.

Entities:  

Mesh:

Year:  2010        PMID: 20156369     DOI: 10.1017/S0022215109992763

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  28 in total

1.  A Novel Surgery Classification for Endoscopic Approaches to Middle Ear Cholesteatoma.

Authors:  Yu Sun; En-Hao Wang; Jin-Tao Yu; Gang Zhong; Li-Xin Zhu; Yi Wang; Niu Xun; Hong Yu; Wen Zhou; Zhen Xie; Kun Zhang; Guo-Run Fan; Yi Zhong; Hong-Jun Xiao; Wei-Jia Kong
Journal:  Curr Med Sci       Date:  2020-03-13

2.  A new theory interprets the development of a retraction pocket as a natural self-healing process.

Authors:  Karl-Bernd Hüttenbrink
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-12       Impact factor: 2.503

3.  Otoscope fogging: examination finding for perforated tympanic membrane.

Authors:  Jason F Naylor
Journal:  BMJ Case Rep       Date:  2014-05-30

4.  A 3-D analysis of the protympanum in human temporal bones with chronic ear disease.

Authors:  Henrique F Pauna; Rafael C Monsanto; Patricia Schachern; Michael M Paparella; Sebahattin Cureoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-22       Impact factor: 2.503

5.  Update From the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2017-02-28

6.  Oxidative stress in chronic otitis media.

Authors:  Elif Baysal; Nurten Aksoy; Ferit Kara; Seyithan Taysi; Abdullah Taşkın; Hasan Bilinç; Cengiz Cevik; Fatih Celenk; Muzaffer Kanlıkama
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-19       Impact factor: 2.503

7.  Use of non-echo-planar diffusion-weighted MR imaging for the detection of cholesteatomas in high-risk tympanic retraction pockets.

Authors:  A Alvo; C Garrido; Á Salas; G Miranda; C E Stott; P H Delano
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

8.  Is endoscopic ear surgery an alternative to the modified Bondy technique for limited epitympanic cholesteatoma?

Authors:  Sampath Chandra Prasad; Annalisa Giannuzzi; Eyad Abu Nahleh; Giuseppe De Donato; Alessandra Russo; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

9.  Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.

Authors:  Wei Liu; Tuanfang Yin; Jihao Ren; Lihua Li; Zian Xiao; Xing Chen; Dinghua Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-05       Impact factor: 2.503

10.  Eyes in Ears: A Miniature Steerable Digital Endoscope for Trans-Nasal Diagnosis of Middle Ear Disease.

Authors:  Joshua Gafford; Michael Freeman; Loris Fichera; Jack Noble; Robert Labadie; Robert J Webster
Journal:  Ann Biomed Eng       Date:  2020-05-26       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.